Skip to main content
. 2023 Apr 4;41(20):3247–3257. doi: 10.1016/j.vaccine.2023.03.065

Fig. 4.

Fig. 4

Proportion (%) of patients in different treatment groups and controls with positive antibody response after the second and third vaccine dose defined as postvaccination antibody levels over the cut-off (seropositivity) in seronegative patients or ≥ 4-fold increase in antibody levels in patients with seropositivity for both spike antigens.